Psychoactive drugs and pain

  • K. Kouyanou
Part of the Topics in Anaesthesia and Critical Care book series (TIACC)


We will present information on psychoactive drugs used for the management of pain. Opioids are the most potent pain-relieving drugs and are often the drugs of choice in the management of acute severe pain. Opioids are discussed elsewhere in this book. Psychoactive drugs other than opioids are mainly used in chronic pain as adjuvant treatment and have little or no place in the treatment of acute pain. They are mainly comprised by the classes of antidepressants, antipsychotics, anticonvulsants, and anxiolytics. We will briefly present the problem of chronic pain, the medication in chronic pain and the present status of psychoactive drug use.


Chronic Pain Neuropathic Pain Diabetic Neuropathy PsychotropIC Drug Trigeminal Neuralgia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bonica JJ (1990) Definitions and taxonomy of pain. In: Bonica JJ (ed) The management of pain, vol 1, 2nd edn. Lea and Febiger, PhiladelphiaGoogle Scholar
  2. 2.
    Flor H, Turk DC (1984) Etiological theories and treatment for chronic back pain. I. Somatic models and interventions. Pain 19: 105–121Google Scholar
  3. 3.
    Clinical Standards Advisory Group (1994) Report of a CSAG Committee on Back Pain. HMSO, London, p 63Google Scholar
  4. 4.
    Flor H, Fydrich T, Turk DC (1992) Efficacy of multidisciplinary pain treatment centers: a meta-analytic review. Pain 49: 221–230PubMedCrossRefGoogle Scholar
  5. 5.
    Turner JA, Chapman CR (1982) Psychological interventions for chronic pain: a critical review. II. Operant conditioning, hypnosis, and cognitive-behavioural therapy. Pain 12: 23–46Google Scholar
  6. 6.
    Aronoff GM, Evans WO, Enders PL (1983) A review of follow-up studies of multidisciplinary pain units. Pain 16: 1–11PubMedCrossRefGoogle Scholar
  7. 7.
    Linton SJ (1986) Behavioural remediation of chronic pain: a status report. Pain 24: 125–141PubMedCrossRefGoogle Scholar
  8. 8.
    Philips HC (1987) The effects of behavioural treatment on chronic pain. Behav Res Ther 25: 365–377PubMedCrossRefGoogle Scholar
  9. 9.
    Katz WA (1996) Approach to the management of nonmalignant pain. Am J Med 101 (suppl 1A): 54S - 63SPubMedCrossRefGoogle Scholar
  10. 10.
    King SA, Strain JJ (1990) Benzodiazepme use in chronic pain patients. Clin J Pain 6: 143147Google Scholar
  11. 11.
    Turner JA, Calsyn DA, Fordyce WE, Ready LB (1982) Drug utilization patterns in chronic pain patients. Pain 12: 357–363PubMedCrossRefGoogle Scholar
  12. 12.
    Riley J, Ahern D, Follick M (1988) Chronic pain and functional impairment: assessing beliefs about their relationship. Arch Phys Med Rehabil 69: 579–582PubMedGoogle Scholar
  13. 13.
    Fordyce WE (1976) Behavioural methods for chronic pain and illness. Mosby, St LouisGoogle Scholar
  14. 14.
    Weissman D, Haddox D (1989) Opioid pseudoaddiction — an iatrogenic syndrome. Pain 36: 363–366PubMedCrossRefGoogle Scholar
  15. 15.
    Maruta T, Swanson DW, Fmlayson RE (1979) Drug abuse and dependence in patients with chronic pain. Mayo Clin Proc 54: 241–244PubMedGoogle Scholar
  16. 16.
    Ready LB, Sarkis E, Turner JA (1982) Self-reported vs actual use of medication in chronic pain patients. Pain 12: 285–294PubMedCrossRefGoogle Scholar
  17. 17.
    Kouyanou K, Pither CE, Wessely S (1997) Medication misuse, abuse, and dependence in chronic pain patients. J Psychos Res 43: 497–504CrossRefGoogle Scholar
  18. 18.
    Jenkins DG, Ebbutt AF, Evans CD (1976) Tofranil in the treatment of low back pain. J Int Med Res 4: 28–40PubMedGoogle Scholar
  19. 19.
    Monks R, Merskey H (1989) Psychotropic drugs. In: Wall PD, Melzack R (eds) Textbook of pain, 2nd ed. Churchill Livingstone, London, pp 702–721Google Scholar
  20. 20.
    McQuay HJ, Carroll D, Glynn CJ (1992) Low dose amitriptyline in the treatment of chronic pain Anaesthesia 47: 646–652Google Scholar
  21. 21.
    Feinmann C (1985) Pain relief by antidepressants: possible modes of action. Pain 23: 1–8PubMedCrossRefGoogle Scholar
  22. 22.
    Lascelles RG (1966) Atypical facial pain and depression. Br J Psychiatry 112: 651–659PubMedCrossRefGoogle Scholar
  23. 23.
    Okasha A, Ghalet HA, Sadek A (1973) A double blind trial for the clinical management of psychogenic headache. Br J Psychiatry 122. 181–185PubMedCrossRefGoogle Scholar
  24. 24.
    Gringas M (1973) A clinical trial of tofranil in rheumatic pain in general practice. J Med Res 4(Suppl 2)•41–49Google Scholar
  25. 25.
    Hameroff SR, Cook RC, Scherer K, Crago BR, Newman C, Wombley JK, Davis TP (1982) Doxepin effects on chronic pain, depression and plasma opioids J Clin Psychiatry 43.22–26 154 K. KouyanouGoogle Scholar
  26. 26.
    Hughes A, Chauvergre J, Lisslour J, Lafgarde C (1963) L’ imipramine, utilisée comme antalgique majeur en carcinologie. étude de 118 cas. Presse Med 71: 1073–1074Google Scholar
  27. 27.
    Sternbach R (1976) The need for an animal model of chronic pain. Pain 2: 2–4PubMedGoogle Scholar
  28. 28.
    Iversen LL (1974) Monoamines in the mammalian nervous system and the actions of antidepressant drugs. In: Iversen LL (ed) Biochemistry and mental illness. Plenum, New York, pp 57–83Google Scholar
  29. 29.
    Lee R, Spencer PSJ (1977) Antidepressants and pain. A review of the pharmacological data supporting the use of certain tricychcs in chronic pain. J Int Med Res 5. 146–156Google Scholar
  30. 30.
    Lance JW, Curran DA (1963) Treatment of chronic tention headache. Lancet 1: 1236 1239Google Scholar
  31. 31.
    Watson CPN, Evans RI, Reed K, Merskey H, Goldsmith L, Warsh J (1982) Amitriptyline versus placebo in post-herpetic neuralgia. Neurology 32: 671–673PubMedGoogle Scholar
  32. 32.
    Feinmann C, Harris M, Cawley R (1984) Psychogenic pain: presentation and treatment. Br Med J 228: 436–438CrossRefGoogle Scholar
  33. 33.
    Shara Y, Singer E, Schmidt E, Dionne RA, Dubner R (1987) The analgesic effect of amitriptyline on chronic facial pain. Pain 31: 199–209CrossRefGoogle Scholar
  34. 34.
    Basbaum AT, Fields HL (1984) Endogenous pain control mechanisms: review and hypothesis. Ann Neurol 4: 451–462CrossRefGoogle Scholar
  35. 35.
    McQuay HJ, Tramèr M, Nye BA, Carroll D, Wiffen PJ, Moore RA (1996) A systematic review of antidepressants in neuropathie pain. Pain 68: 217–227PubMedCrossRefGoogle Scholar
  36. 36.
    Onghena P, Van Houdenhove B (1992) Antidepressant-induced analgesia in chronic non-malignant pain• a meta-analysis of 39 placebo-controlled studies. Pain 49. 205–219PubMedCrossRefGoogle Scholar
  37. 37.
    Volmmk J, Lancaster T, Gray S, Silagy C (1996) Treatments of postherpetic neuralgia: a systematic review of randomized controlled trials. Fam Pract 13: 84–91CrossRefGoogle Scholar
  38. 38.
    Max MB, Lynch SA, Muir J, Shoaf SF, Smoller B, Dubner R (1992) Effects of desipramine, amitriptyline, and fluoxetine on pain on diabetic neuropathy. N Engl J Med 326: 1250–1256PubMedCrossRefGoogle Scholar
  39. 39.
    Leijon G, Bowie J (1989) Central post-stroke pain: a controlled trial of amitriptylme and carbamazepine. Pain 36: 27–36PubMedCrossRefGoogle Scholar
  40. 40.
    Sindrup SH, Bjerre U, Dejgaard A, Brosen K, Aaes-Jorgensen T, Gram LF (1992b) The serotonm reuptake inhibitor citalopram relieves symptoms of diabetic neuropathy. Clin Pharmacol Ther 52: 547–552PubMedCrossRefGoogle Scholar
  41. 41.
    Loesser JD (1994) Tic douloureaux and atypical facial pain. In: Wall PD, Melzack R (eds) Textbook of pain, 3rd ed. Churchill Livingstone, London, pp 699–710Google Scholar
  42. 42.
    Twycross R (1994) The management of pain in cancer. In: Nimmo WS, Rowbotham DJ, Smith G (eds) Anaesthesia, 2nd ed. Blackwell, Oxford, pp 1635–1651Google Scholar
  43. 43.
    Monks R (1994) Psychotropic drugs. In: Wall PD, Melzack R (eds) Textbook of pain, 3rd ed. Churchill Livingstone, London, pp 963–989Google Scholar
  44. 44.
    Reynolds JEF (1993) Martindale: the extra pharmacopoeia, 30th ed. Pharmaceutical Press, London, pp 292–314Google Scholar
  45. 45.
    Graham-Smith DG, Aronson JK (1992) Oxford textbook of clinical pharmacology and drug therapy, 2nd ed. Oxford University Press, Oxford, pp 433–436, 529–717Google Scholar
  46. 46.
    McQuay H, Carroll D, Jada AR, Wiffen P, Moore A (1995) Anticonvulsant drugs for managementof pain: a systematic review. Br Med J 311: 1047–1052CrossRefGoogle Scholar
  47. 47.
    Martin C, Martin A, Rud C, Valli M (1988) Comparative study of sodium valporate and ketoprofen in the treatment of postoperative pain. Ann Fr Anaesth Reanim 7: 387–392CrossRefGoogle Scholar
  48. 48.
    Keczkes K, Basheer AM (1980) Do corticosteroids prevent post-herpetic neuralgia? Br J Dermatol 102: 551–555PubMedCrossRefGoogle Scholar
  49. 49.
    Hendler N, Cimmi C, Ma T, Long D (1980) A comparison of cognitive impairement due to benzodiazepmes and to narcotics. Am J Psychiatry 137: 828–830PubMedGoogle Scholar
  50. Psychoactive drugs and pain 155Google Scholar
  51. 50.
    King SA, Strain JJ (1990) Benzodiazepine use by chronic pain patients. Clin Pain 6: 143147Google Scholar
  52. 51.
    Mellinger GD, Baiter MB, Uhlenbuth EH (1984) Prevalence and correlates of long-term regular use of anxiolytics. JAMA 251: 375–379PubMedCrossRefGoogle Scholar
  53. 52.
    Turner JA, Calsyn DA, Fordyce WE, Ready LB (1982) Drug utilization patterns in chronic pain patients. Pain 12: 357–363PubMedCrossRefGoogle Scholar
  54. 53.
    Ziesat HA, Angle HV, Gentry WD, Ellinwood EH (1979) Drug use and misuse in operant pain patients. Addict Beh 4: 263–266CrossRefGoogle Scholar
  55. 54.
    Hollister LE, Conley FK, Britt RH, Shuer L (1981) Long-term use of diazepam. JAMA 246: 1568–1570Google Scholar
  56. 55.
    Atkinson JH, Ancoli-Israel S, Slater MA, Garfin SR, Gillin JC (1988) Subjective sleep disturbance in chronic back pain. Clin J Pain 4: 225–232CrossRefGoogle Scholar
  57. 56.
    Pilowsky I, Crettenden I, Townley M (1985) Sleep disturbance in pain clinic patients. Pain 23: 27–33PubMedCrossRefGoogle Scholar
  58. 57.
    Greenblat DJ, Shader RJ, Abernethy DR (1983) Current status of benzodiazepines. New Engl J Med 309: 410–416CrossRefGoogle Scholar
  59. 58.
    Haefely W (1985) The biological basis of benzodiazepine actions. In: Smith DE, Wesson DR (eds) The benzodiazepines: current standards for medical practice. MTP Press, Lancaster, pp 7–41CrossRefGoogle Scholar
  60. 59.
    Mantegazza D, Tammiso R, Vincentini L, Zambotti F, Zonta N (1980) The effects of GABAergic agents on opiate analgesia. Pharmacol Res Commun 12: 239–247PubMedCrossRefGoogle Scholar
  61. 60.
    Adams JE (1989) News from the council on research: task force on benzodiazepine dependency. Psychiatry Res Rep 4: 3Google Scholar
  62. 61.
    Kocher R (1976) The use of psychotropic drugs in the treatment of chronic severe pains. Eur Neurol 14: 458–464PubMedCrossRefGoogle Scholar
  63. 62.
    Sherwin D (1979) New method for treating “headaches”. Am J Psychiatry 136: 11811183Google Scholar
  64. 63.
    Clarke IM (1981) Amitriptyline and perphenazine in chronic pain. Anaesthesia 36: 210212Google Scholar
  65. 64.
    Wang SJ, Silberstein SD, Young WB (1997) Droperidol treatment of status migramosus and refractory migraine. Headache 37: 377–382PubMedCrossRefGoogle Scholar

Copyright information

© Springer Verlag Italia, Milano 1999

Authors and Affiliations

  • K. Kouyanou

There are no affiliations available

Personalised recommendations